Endorser status and explicitness of payment in direct-to-consumer promotion
Ended Awarded Last action
- Contract number
- 75F40118F18002
- Awardee
-
Westat, Inc. UEI NVUWAFWQ57S5
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $447,205
Award facts
- Opportunity
-
- FDARFTOP1195821 Solicitation number
- Contract value 100% obligated
- $447,205.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541820 Public Relations Agencies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Original award | $447,205 |
About this award
The Food and Drug Administration awarded a $447,205 firm fixed-price contract to Westat, Inc. under the AIMS GSA Schedule on September 7, 2018, with completion targeted for September 11, 2022. The award was issued as a BPA Call (Blanket Purchase Agreement call order) without a small business set-aside. The contract supports FDA's Quick Turnaround Social Science Research Services program and addresses research on endorser status and explicitness of payment in direct-to-consumer promotion—a regulatory focus area for the agency's consumer protection and marketing oversight functions. Performance of work was conducted at Westat's Silver Spring, Maryland location.
Westat, Inc., a large for-profit research and technical services firm headquartered in Rockville, Maryland, is well-positioned to execute this engagement based on its extensive track record with federal agencies. The company specializes in survey research, data collection, statistical analysis, and program evaluation services and maintains significant federal contract vehicles across multiple agencies including the FDA, CDC, NIH, and USDA. This particular engagement reflects Westat's core competency in providing rapid-turnaround social science research to support government policy and regulatory initiatives, leveraging the firm's established expertise in consumer research and marketing analysis to inform FDA's regulatory decision-making regarding advertising practices.
Quick answers
Who was awarded contract 75F40118F18002?
75F40118F18002 was awarded to Westat, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 7, 2018.
How much is contract 75F40118F18002 worth?
The government has obligated $447,205 on 75F40118F18002.
Is contract 75F40118F18002 an order under another contract?
Yes. 75F40118F18002 is a BPA call under GS23F0155K-HHSF223201510001B, a blanket purchase agreement, on Advertising & Integrated Marketing Solutions (AIMS).
Was contract 75F40118F18002 competed?
The extent of competition for 75F40118F18002 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award